Cargando…

Infections after fiducial marker implantation for prostate radiotherapy: are we underestimating the risks?

BACKGROUND: The use of gold fiducial markers (FM) for prostate image-guided radiotherapy (IGRT) is standard practice. Published literature suggests low rates of serious infection following this procedure of 0-1.3%, but this may be an underestimate. We aim to report on the infection incidence and sev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loh, Jasmin, Baker, Katie, Sridharan, Swetha, Greer, Peter, Wratten, Chris, Capp, Anne, Gallagher, Sarah, Martin, Jarad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333155/ https://www.ncbi.nlm.nih.gov/pubmed/25890179 http://dx.doi.org/10.1186/s13014-015-0347-2

Ejemplares similares

Visualising the urethra for prostate radiotherapy planning
por: Richardson, Matthew, et al.
Publicado: (2021)

Prostate deformation during hypofractionated radiotherapy: an analysis of implanted fiducial marker displacement
por: Knybel, Lukas, et al.
Publicado: (2021)

Fiducial markers in prostate cancer image-guided radiotherapy
por: Ghaffari, Hamed, et al.
Publicado: (2019)

Recommendation of fiducial marker implantation for better target tracking using MV imager in prostate radiotherapy
por: Ma, Tianjun, et al.
Publicado: (2018)

Potentials of on-line repositioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapy
por: Graf, Reinhold, et al.
Publicado: (2009)

Effects of Gold Fiducial Marker Implantation on Tumor Control and Toxicity in External Beam Radiotherapy of Prostate Cancer
por: Moll, Matthias, et al.
Publicado: (2023)

Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers
por: Skarsgard, David, et al.
Publicado: (2010)

Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging
por: Osman, Sarah O. S., et al.
Publicado: (2019)

Intraprostatic fiducial markers: a potential application for ultrasound-guided radiotherapy in prostate cancer
por: Vavassori, A, et al.
Publicado: (2009)

Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy
por: Maspero, Matteo, et al.
Publicado: (2018)

Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI
por: Pathmanathan, Angela U., et al.
Publicado: (2019)

Cardiac embolization of an implanted fiducial marker for hepatic stereotactic body radiotherapy: a case report
por: Hennessey, Hooman, et al.
Publicado: (2009)

Accuracy of an MR-only workflow for prostate radiotherapy using semi-automatically burned-in fiducial markers
por: Goudschaal, Karin, et al.
Publicado: (2021)

Absence of prostate oedema obviates the need for delay between fiducial marker insertion and radiotherapy simulation
por: Patel, Deepti, et al.
Publicado: (2020)

Carbon ion radiotherapy using fiducial markers for prostate cancer in Osaka HIMAK: Treatment planning
por: Tsubouchi, Toshiro, et al.
Publicado: (2021)

Safety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking
por: Scher, Nathaniel, et al.
Publicado: (2019)

A Multi-center Prospective Study for Implementation of an MRI-Only Prostate Treatment Planning Workflow
por: Greer, Peter, et al.
Publicado: (2019)

Transarterial fiducial marker implantation for CyberKnife radiotherapy to treat pancreatic cancer: an experience with 14 cases
por: Imaizumi, Akira, et al.
Publicado: (2020)

A clinical study comparing polymer and gold fiducials for prostate cancer radiotherapy
por: Lim Joon, Daryl, et al.
Publicado: (2023)

FDG-PET parameters predict for recurrence in anal cancer – results from a prospective, multicentre clinical trial
por: Jones, Michael Peter, et al.
Publicado: (2019)

Simple method for correcting imperfectly placed fiducial markers for image-guided radiotherapy technologies of the prostate cancer
por: Gawlik-Jakubczak, Teresa
Publicado: (2022)

A prospective study of nomogram-based adaptation of prostate radiotherapy target volumes
por: Wu, Raymond, et al.
Publicado: (2015)

EUS-guided fiducial marker placement for radiotherapy in rectal cancer: feasibility of two placement strategies and four fiducial types
por: Rigter, Lisanne S., et al.
Publicado: (2019)

Radiopaque drug-eluting embolisation beads as fiducial markers for stereotactic liver radiotherapy
por: Beaton, Laura, et al.
Publicado: (2022)

Correction to: Transarterial fiducial marker implantation for CyberKnife radiotherapy to treat pancreatic cancer: an experience with 14 cases
por: Imaizumi, Akira, et al.
Publicado: (2023)

Observed high incidence of prostatic calculi with the potential to act as natural fiducials for prostate image guided radiotherapy
por: O'Neill, A.G.M., et al.
Publicado: (2019)

Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy
por: Habermehl, Daniel, et al.
Publicado: (2013)

The use of tissue fiducial markers in improving the accuracy of post-prostatectomy radiotherapy
por: Chao, Michael, et al.
Publicado: (2019)

Investigation into the use of a MOSFET dosimeter as an implantable fiducial marker
por: Kry, Stephen F, et al.
Publicado: (2009)

Prostate Fiducial Marker Placement in Patients on Anticoagulation: Feasibility Prior to Prostate SBRT
por: Iocolano, Michelle, et al.
Publicado: (2020)

Intratumoural renal cell carcinoma haemorrhage following stereotactic radiotherapy: a case report
por: Hilleary, Liam A., et al.
Publicado: (2019)

Intra-prostatic gold fiducial marker insertion for image-guided radiotherapy (IGRT): five-year experience on 795 patients
por: Mahdavi, Ali, et al.
Publicado: (2023)

Validation of an MRI-only planning workflow for definitive pelvic radiotherapy
por: O’Connor, Laura M., et al.
Publicado: (2022)

Fiducial marker implantation using convex probe EBUS and autologous blood
por: Garner, Justin L, et al.
Publicado: (2019)

Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer
por: Sridharan, Swetha, et al.
Publicado: (2022)

Phase 2 Multicenter Study of Gantry-Based Stereotactic Radiotherapy Boost for Intermediate and High Risk Prostate Cancer (PROMETHEUS)
por: Pryor, David, et al.
Publicado: (2019)

Minimal Inter-Fractional Fiducial Migration during Image-Guided Lung Stereotactic Body Radiotherapy Using SuperLock Nitinol Coil Fiducial Markers
por: Rong, Yi, et al.
Publicado: (2015)

Dose reduction potential of using gold fiducial markers for kilovoltage image‐guided radiotherapy
por: Takei, Yoshiki, et al.
Publicado: (2020)

The factors of fiducial marker motions and individual margin assessment in postoperative breast cancer radiotherapy
por: Luo, Jiaojiao, et al.
Publicado: (2022)

A liquid immunogenic fiducial eluter for image-guided radiotherapy
por: Moreau, Michele, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lpung71ie941j779f6flkdk8mt